Literature DB >> 6659223

Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma.

W G Walsh, P Tomashefsky, C A Olsson, R deVere White.   

Abstract

The antigenicity of transitional cell carcinoma of the bladder has stimulated the search for effective immunotherapeutic agents in the treatment of this disease. Non-specific immunotherapy with local (intravesical/intralesional) and systemic Keyhole Limpet Haemocyanin (KLH) in a FANFT induced murine bladder tumor model was studied. Results showed no difference between control or treated groups in either tumor growth or animal survival.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6659223     DOI： 10.1007/BF00256343

Source DB:  PubMed          Journal:  Urol Res        ISSN： 0300-5623


  18 in total

1.  Susceptibility of urothelium to neoplastic cellular implantation.

Authors:  T E Weldon; M S Soloway
Journal:  Urology       Date:  1975-06       Impact factor: 2.649

2.  Bacillus Calmette-Guerin immunotherapy of the cancer-contaminated wound.

Authors:  D L Lamm; D F Reichert; H M Radwin; D E Thor
Journal:  J Surg Res       Date:  1979-07       Impact factor: 2.192

3.  The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

Authors:  J E Curtis; E M Hersh; J E Harris; C McBride; E J Freireich
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

4.  Immunologic reduction of bladder cancer recurrence rate.

Authors:  C A Olsson; R Chute; C N Rao
Journal:  J Urol       Date:  1974-02       Impact factor: 7.450

5.  Demonstration of specific antigen in N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide induced rat bladder tumor.

Authors:  J J Daly; G R Prout; C A Ahl
Journal:  J Urol       Date:  1973-02       Impact factor: 7.450

6.  The human secondary immune response to Keyhole limpet haemocyanin.

Authors:  J E Curtis; E M Hersh
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

7.  Cellular and humoral immune responses to human urinary bladder carcinomas.

Authors:  J Bubeník; P Perlmann; K Helmstein; G Moberger
Journal:  Int J Cancer       Date:  1970-05-15       Impact factor: 7.396

8.  Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma.

Authors:  S Kagawa; K Ogura; K Kurokawa; K Uyama
Journal:  J Urol       Date:  1979-10       Impact factor: 7.450

9.  Immunological studies on urinary bladder tumors of rats and mice.

Authors:  L A Taranger; W H Chapman; I Hellström; K E Hellström
Journal:  Science       Date:  1972-06-23       Impact factor: 47.728

10.  Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.

Authors:  C O'Toole; V Stejskal; P Perlmann; M Karlsson
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307
View more
  1 in total

1.  Induction of the TRPM-2 gene in cells undergoing programmed death.

Authors:  R Buttyan; C A Olsson; J Pintar; C Chang; M Bandyk; P Y Ng; I S Sawczuk
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.